Authors:
Muntwyler, J
Amann, FW
Gutzwiller, F
Follath, F
Citation: J. Muntwyler et al., Lipid-lowering drugs among patients with coronary artery disease: proportion of patients requiring treatment according to recommendations of the Swiss Society of Cardiology 1999, SCHW MED WO, 129(50), 1999, pp. 1959-1963
Citation: Mp. Fischler et F. Follath, Comparative assessment of ACE inhibitors: what differences are relevant?, SCHW MED WO, 129(29-30), 1999, pp. 1053-1060
Authors:
Brunner-La Rocca, HP
Weilenmann, D
Kiowski, W
Maly, FE
Follath, F
Citation: Hp. Brunner-la Rocca et al., Plasma levels of enalaprilat in chronic therapy of heart failure: Relationship to adverse events, J PHARM EXP, 289(1), 1999, pp. 565-571
Authors:
Brunner-La Rocca, HP
Weilenmann, D
Rickli, H
Follath, F
Kiowski, W
Citation: Hp. Brunner-la Rocca et al., Is blood pressure response to the Valsalva maneuver related to neurohormones, exercise capacity, and clinical findings in heart failure?, CHEST, 116(4), 1999, pp. 861-867
Citation: M. Togni et al., Spontaneous multivessel coronary artery dissection in a pregnant woman treated successfully with stent implantation, AM J MED, 107(4), 1999, pp. 407-408
Authors:
Brunner-La Rocca, HP
Weilenmann, D
Schalcher, C
Schlumpf, M
Follath, F
Candinas, R
Kiowski, W
Citation: Hp. Brunner-la Rocca et al., Prognostic significance of oxygen uptake kinetics during low level exercise in patients with heart failure, AM J CARD, 84(6), 1999, pp. 741
Authors:
Follath, F
Hinkka, S
Jager, D
Just, H
Mitrovic, V
Papp, JG
Peuhkurinen, K
Sandell, EP
Takkunen, O
Lehtonen, L
Citation: F. Follath et al., Dose-ranging and safety with intravenous levosimendan in low-output heart failure: Experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trial, AM J CARD, 83(12B), 1999, pp. 21I-25I
Authors:
Brunner-La Rocca, HP
Weilenmann, D
Kiowski, W
Maly, FE
Candinas, R
Follath, F
Citation: Hp. Brunner-la Rocca et al., Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure, AM HEART J, 138(4), 1999, pp. 654-662